Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lopatin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nursing Times|August 4, 1998
On track for healthW Lopatin
The Health Service Journal|September 19, 1997
Information services. Knowledge is powerW Lopatin, P Blagden
Clinical Chemistry|September 1, 1986
Application of pattern-recognition techniques in wavelength selection for instrumentally read reagent stripsA Y Chu, W Lopatin
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 1, 1983
Unexplained hematuriaM Barkin, W Lopatin, S Herschorn, et al.
Clinical Nephrology|January 1, 1986
Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandinsL Makowka, W Lopatin, T Gilas, et al.
Advances in Experimental Medicine and Biology|January 1, 1987
Prostaglandin E2 (PGE2) alters the pathogenesis of MHV-3 infection in susceptible BALB/cJ miceM Abecassis, J Falk, V Dindzans, et al.
Transplantation Proceedings|February 1, 1987
Prostaglandin E2 prevents fulminant hepatitis and the induction of procoagulant activity in susceptible animalsM Abecassis, J Falk, V Dindzans, et al.
The American Journal of Medicine|August 1, 1984
Reliability of blood glucose monitoring by patients with diabetes mellitusR S Mazze, H Shamoon, R Pasmantier, et al.
Contributions to Nephrology|January 1, 1989
Cadaveric renal transplantation under the American organ allocation systemR Shapiro, A G Tzakis, T R Hakala, et al.
Clinical Transplants|January 1, 1988
Cadaveric renal transplantation at the University of Pittsburgh: a two and one-half-year experience with the point systemR Shapiro, A G Tzakis, T R Hakala, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nursing Times|August 4, 1998
On track for healthW Lopatin
The Health Service Journal|September 19, 1997
Information services. Knowledge is powerW Lopatin, P Blagden
Clinical Chemistry|September 1, 1986
Application of pattern-recognition techniques in wavelength selection for instrumentally read reagent stripsA Y Chu, W Lopatin
Canadian Journal of Surgery. Journal Canadien De Chirurgie|November 1, 1983
Unexplained hematuriaM Barkin, W Lopatin, S Herschorn, et al.
Clinical Nephrology|January 1, 1986
Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandinsL Makowka, W Lopatin, T Gilas, et al.
Advances in Experimental Medicine and Biology|January 1, 1987
Prostaglandin E2 (PGE2) alters the pathogenesis of MHV-3 infection in susceptible BALB/cJ miceM Abecassis, J Falk, V Dindzans, et al.
Transplantation Proceedings|February 1, 1987
Prostaglandin E2 prevents fulminant hepatitis and the induction of procoagulant activity in susceptible animalsM Abecassis, J Falk, V Dindzans, et al.
The American Journal of Medicine|August 1, 1984
Reliability of blood glucose monitoring by patients with diabetes mellitusR S Mazze, H Shamoon, R Pasmantier, et al.
Contributions to Nephrology|January 1, 1989
Cadaveric renal transplantation under the American organ allocation systemR Shapiro, A G Tzakis, T R Hakala, et al.
Clinical Transplants|January 1, 1988
Cadaveric renal transplantation at the University of Pittsburgh: a two and one-half-year experience with the point systemR Shapiro, A G Tzakis, T R Hakala, et al.
Pageof 1